中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
14期
18-19
,共2页
急性下壁心梗%溶栓治疗%并发症
急性下壁心梗%溶栓治療%併髮癥
급성하벽심경%용전치료%병발증
Acute inferior wal myocardial infarction%Thrombolytic therapy%Complications
目的:对急性下壁心梗溶栓治疗以及该治疗的并发症联系进行探讨分析。方法2010年~2013年我院共接收80例急性下壁心梗患者,对这些患者的临床治疗情况进行回顾分析,全部患者分为对照组和观察组,均有40例,观察组患者使用半量瑞替普酶溶栓治疗,对照组使用尿激酶溶栓治疗,对患者的临床治疗情况以及并发症情况对比分析。结果观察组患者的血管再通率是85%,对照组患者的再通率是45%,观察组比对照组再通率高,P<0.05。患者梗死后心绞痛、心源性休克、心律失常等并发症发生率较观察组低,P<0.05。结论急性下壁心梗使用半量瑞替普酶溶栓治疗的效果要比尿激酶优秀,患者使用后的并发症也比尿激酶低,因此在临床中我们更推介使用半量瑞替普酶溶栓治疗。
目的:對急性下壁心梗溶栓治療以及該治療的併髮癥聯繫進行探討分析。方法2010年~2013年我院共接收80例急性下壁心梗患者,對這些患者的臨床治療情況進行迴顧分析,全部患者分為對照組和觀察組,均有40例,觀察組患者使用半量瑞替普酶溶栓治療,對照組使用尿激酶溶栓治療,對患者的臨床治療情況以及併髮癥情況對比分析。結果觀察組患者的血管再通率是85%,對照組患者的再通率是45%,觀察組比對照組再通率高,P<0.05。患者梗死後心絞痛、心源性休剋、心律失常等併髮癥髮生率較觀察組低,P<0.05。結論急性下壁心梗使用半量瑞替普酶溶栓治療的效果要比尿激酶優秀,患者使用後的併髮癥也比尿激酶低,因此在臨床中我們更推介使用半量瑞替普酶溶栓治療。
목적:대급성하벽심경용전치료이급해치료적병발증련계진행탐토분석。방법2010년~2013년아원공접수80례급성하벽심경환자,대저사환자적림상치료정황진행회고분석,전부환자분위대조조화관찰조,균유40례,관찰조환자사용반량서체보매용전치료,대조조사용뇨격매용전치료,대환자적림상치료정황이급병발증정황대비분석。결과관찰조환자적혈관재통솔시85%,대조조환자적재통솔시45%,관찰조비대조조재통솔고,P<0.05。환자경사후심교통、심원성휴극、심률실상등병발증발생솔교관찰조저,P<0.05。결론급성하벽심경사용반량서체보매용전치료적효과요비뇨격매우수,환자사용후적병발증야비뇨격매저,인차재림상중아문경추개사용반량서체보매용전치료。
Objective To investigate relationship between thrombolytic therapy of acute inferior wal myocardial infarction and complications.Methods Selected 80 cases of acute inferior wal myocardial infarction patients to study from 2010 to 2013 in our hospital. Clinical treatment of these patients were analyzed retrospectively. Al patients were grouped into control group and observation group,were 40 cases. Use half reteplase in the observation group,use urokinase in the control group. Clinical treatment and complications of patients were analyzed. ResultsThe observation group of patients with recanalization rate was 85 percent. The control group of patients with recanalization rate was 45 percent. Recanalization rate in the observation group was higher than the control group,P< 0.05. Angina,cardiogenic shock,arrhythmias,such as the incidence of complications in patients after myocardial infarction was lower than that observed,P< 0.05.Conclusion Acute inferior wal myocardial infarction using half the amount of reteplase is better than thrombolytic therapy with urokinase,the complication rate in patients is lower than urokinase. Therefore,we recommend using half the amount of reteplase for thrombolytic therapy.